Novartis’ Beovu safety woes could cost billions of dollars, says analystThe launch of Novartis’ Beovu ophthalmology drug could be compromised after a safety warning from doctors over several Share XNovartis’ Beovu safety woes could cost billions of dollars, says analysthttps://pharmaphorum.com/news/novartis-beovu-launch-could-be-hit-by-safety-warning/
Jury trial levies $750m damages on J&J over talc and cancerThe jury in a New Jersey trial has awarded $750 million in punitive damages against Johnson & Johnson Share XJury trial levies $750m damages on J&J over talc and cancerhttps://pharmaphorum.com/news/jury-trial-levies-750m-damages-on-jj-over-talc-and-cancer/
FDA slaps hold on Zolgensma trials as animal data raises safety questionThe FDA has placed a partial clinical hold on Novartis’ recently-approved gene therapy Zolgensma for spinal muscular atrophy Share XFDA slaps hold on Zolgensma trials as animal data raises safety questionhttps://pharmaphorum.com/news/fda-slaps-hold-on-zolgensma-trials-as-animal-data-raises-safety-question/
Major US retailers pull J&J’s talc from shelves over asbestos fearsA trio of major US retailers including Walmart are removing all 22-ounce bottles of Johnson & Johnson’s baby Share XMajor US retailers pull J&J’s talc from shelves over asbestos fearshttps://pharmaphorum.com/news/major-us-retailers-pull-jjs-talc-from-shelves-over-asbestos-fears/
Lawsuit-laden J&J recalls baby powder after asbestos alertJohnson & Johnson has said it is recalling around 33,000 bottles of baby powder in the US, after Share XLawsuit-laden J&J recalls baby powder after asbestos alerthttps://pharmaphorum.com/news/lawsuit-laden-jj-recalls-baby-powder-after-asbestos-alert/
Multiple pharmas pull ranitidine stomach drugs amid growing cancer scareSupplies of the heartburn drug ranitidine have been recalled globally following a cancer scare involving multiple pharma companies, Share XMultiple pharmas pull ranitidine stomach drugs amid growing cancer scarehttps://pharmaphorum.com/news/multiple-pharmas-pull-ranitidine-stomach-drugs-amid-growing-cancer-scare/
France’s Servier finally goes on trial over Mediator safety scandalMore than a decade after a scandal over drug safety in France first broke, the pharma company Servier Share XFrance’s Servier finally goes on trial over Mediator safety scandalhttps://pharmaphorum.com/news/frances-servier-finally-goes-on-trial-over-mediator-safety-scandal/
EU safety experts begin review of leuprorelin-containing drugsEuropean safety experts are to begin a review of leuprorelin-containing medicines, commonly used in breast and prostate cancer Share XEU safety experts begin review of leuprorelin-containing drugshttps://pharmaphorum.com/news/eu-safety-experts-begin-review-of-leuprorelin-containing-drugs/
Teva expands blood pressure drug recall in the US amid cancer fearsTeva has expanded a recall of losartan potassium tablets after tests revealed a potential human carcinogen in the Share XTeva expands blood pressure drug recall in the US amid cancer fearshttps://pharmaphorum.com/news/teva-expands-blood-pressure-drug-recall-in-the-us-amid-cancer-fears/
